% differences compared with placebo or indicated statin are based on differences of individual least square means for LDL-C, HDL-C, non-HDL-C and apoB, and on differences of individual medians or ...

Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...

In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...

The company said it expects the data to support global regulatory submissions for the drug combination containing obicetrapib 10 mg and ezetimibe 10 mg. However, following a trading halt ...

% differences compared with placebo or indicated statin are based on differences of individual least square means for LDL-C, HDL-C, non-HDL-C and apoB, and on differences of individual medians or ...